ESC-Leitlinien 2023 zum Management der Endokarditis: Was ist neu?

Suzanne de Waha; Steffen Desch; Roland Tilz; Julia Vogler; Madlen Uhlemann; Mateo Marín-Cuartas; Matthias Raschpichler; Michael Borger

doi:10.1007/s00059-023-05225-y

ESC-Leitlinien 2023 zum Management der Endokarditis: Was ist neu?

Translated title of the contribution: ESC guidelines 2023 on the management of endocarditis: What is new?

Suzanne de Waha^*, Steffen Desch, Roland Tilz, Julia Vogler, Madlen Uhlemann, Mateo Marín-Cuartas, Matthias Raschpichler, Michael Borger

^*Corresponding author for this work

University of Leipzig

1 Citation (Scopus)

Abstract

In August 2023 the new European guidelines on the management of infective endocarditis were published by the European Society of Cardiology (ESC). Numerous recommendations were revised and supplemented by new ones. This review article outlines the essential modifications of the current ESC guidelines focusing on the prevention including antibiotic prophylaxis, the role of the endocarditis team, the revision of the diagnostic criteria, the paradigm shift towards oral antibiotic treatment, the timing and the indications for surgical treatment as well as the relevance of infections of cardiovascular implantable electronic devices.

Translated title of the contribution	ESC guidelines 2023 on the management of endocarditis: What is new?
Original language	German
Journal	Herz
Volume	49
Issue number	1
Pages (from-to)	33-42
Number of pages	10
ISSN	0340-9937
DOIs	https://doi.org/10.1007/s00059-023-05225-y
Publication status	Published - 02.2024

Research Areas and Centers

Centers: Cardiological Center Luebeck (UHZL)

DFG Research Classification Scheme

205-12 Cardiology, Angiology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s00059-023-05225-y

Cite this

@article{db1845db8835493f80ce42e22da0dce5,

title = "ESC-Leitlinien 2023 zum Management der Endokarditis: Was ist neu?",

abstract = "In August 2023 the new European guidelines on the management of infective endocarditis were published by the European Society of Cardiology (ESC). Numerous recommendations were revised and supplemented by new ones. This review article outlines the essential modifications of the current ESC guidelines focusing on the prevention including antibiotic prophylaxis, the role of the endocarditis team, the revision of the diagnostic criteria, the paradigm shift towards oral antibiotic treatment, the timing and the indications for surgical treatment as well as the relevance of infections of cardiovascular implantable electronic devices.",

author = "{de Waha}, Suzanne and Steffen Desch and Roland Tilz and Julia Vogler and Madlen Uhlemann and Mateo Mar{\'i}n-Cuartas and Matthias Raschpichler and Michael Borger",

note = "Publisher Copyright: {\textcopyright} 2023, The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.",

year = "2024",

month = feb,

doi = "10.1007/s00059-023-05225-y",

language = "Deutsch",

volume = "49",

pages = "33--42",

journal = "Herz",

issn = "0340-9937",

number = "1",

}

TY - JOUR

T1 - ESC-Leitlinien 2023 zum Management der Endokarditis

T2 - Was ist neu?

AU - de Waha, Suzanne

AU - Desch, Steffen

AU - Tilz, Roland

AU - Vogler, Julia

AU - Uhlemann, Madlen

AU - Marín-Cuartas, Mateo

AU - Raschpichler, Matthias

AU - Borger, Michael

PY - 2024/2

Y1 - 2024/2

N2 - In August 2023 the new European guidelines on the management of infective endocarditis were published by the European Society of Cardiology (ESC). Numerous recommendations were revised and supplemented by new ones. This review article outlines the essential modifications of the current ESC guidelines focusing on the prevention including antibiotic prophylaxis, the role of the endocarditis team, the revision of the diagnostic criteria, the paradigm shift towards oral antibiotic treatment, the timing and the indications for surgical treatment as well as the relevance of infections of cardiovascular implantable electronic devices.

AB - In August 2023 the new European guidelines on the management of infective endocarditis were published by the European Society of Cardiology (ESC). Numerous recommendations were revised and supplemented by new ones. This review article outlines the essential modifications of the current ESC guidelines focusing on the prevention including antibiotic prophylaxis, the role of the endocarditis team, the revision of the diagnostic criteria, the paradigm shift towards oral antibiotic treatment, the timing and the indications for surgical treatment as well as the relevance of infections of cardiovascular implantable electronic devices.

UR - http://www.scopus.com/inward/record.url?scp=85179687620&partnerID=8YFLogxK

UR - https://www.mendeley.com/catalogue/da456190-1d0e-3d2c-8589-ce683ff1dcbe/

U2 - 10.1007/s00059-023-05225-y

DO - 10.1007/s00059-023-05225-y

M3 - Übersichtsarbeiten

C2 - 38092975

AN - SCOPUS:85179687620

SN - 0340-9937

VL - 49

SP - 33

EP - 42

JO - Herz

JF - Herz

IS - 1

ER -

ESC-Leitlinien 2023 zum Management der Endokarditis: Was ist neu?

Abstract

Research Areas and Centers

DFG Research Classification Scheme

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this